<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">39353960</PMID><DateCompleted><Year>2024</Year><Month>10</Month><Day>01</Day></DateCompleted><DateRevised><Year>2024</Year><Month>10</Month><Day>04</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">2045-2322</ISSN><JournalIssue CitedMedium="Internet"><Volume>14</Volume><Issue>1</Issue><PubDate><Year>2024</Year><Month>Oct</Month><Day>01</Day></PubDate></JournalIssue><Title>Scientific reports</Title><ISOAbbreviation>Sci Rep</ISOAbbreviation></Journal><ArticleTitle>Impact of the COVID-19 pandemic on patients with peripheral arterial disease in China: a multicenter cross-sectional study.</ArticleTitle><Pagination><StartPage>22788</StartPage><MedlinePgn>22788</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">22788</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1038/s41598-024-71247-z</ELocationID><Abstract><AbstractText>This study aims to understand the repercussions of the COVID-19 pandemic on hospitalized patients with peripheral arterial disease (PAD) in China, who did not contract SARS-CoV-2. We conducted a multicenter cross-sectional analysis comparing the characteristics and outcomes of hospitalized PAD patients across two distinct periods: Pre-pandemic (P1, from January 2018 to December 2019) and during the pandemic (P2, from January 2020 to December 2021). During P1, 762 hospitalized patients were treated, with an average age of 72.3 years, while 478 patients were treated in P2, with an average age of 65.1 years. Notably, hospitalized patients admitted during the pandemic (P2) exhibited a significantly higher incidence of chronic limb-threatening ischemia (CLTI, 70% vs 54%), diabetic foot infection (47% vs 29%), and infra-popliteal lesions (28% vs 22%). Furthermore, these patients demonstrated a marked deterioration in their Rutherford category and an increased mean score in the Wound, Ischemia, and foot Infection classification system (WIfI). Treatment during the pandemic emerged as a predictor of reduced procedural success and increased major adverse limb events. Factors such as the presence of diabetic foot infection, renal impairment, and deteriorating WIfI scores were identified as independent risk indicators for major adverse limb events. Our results demonstrate that intensive care was provided to severe cases of PAD even during the challenging circumstances of the COVID-19 pandemic. Despite the unprecedented pressures on healthcare systems, patients with severe PAD, particularly those with CLTI, continued to receive necessary in-patient care. The findings underscore the importance of timely medical interventions and extended follow-up for patients exhibiting high-risk factors.</AbstractText><CopyrightInformation>© 2024. The Author(s).</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y" EqualContrib="Y"><LastName>Liu</LastName><ForeName>Bin</ForeName><Initials>B</Initials><AffiliationInfo><Affiliation>Division of Xicheng Medical Center, Department of Vascular Surgery, Beijing Friendship Hospital, Capital Medical University, No. 95 Yong'an Road, Xicheng District, Beijing, 100050, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Beijing Center of Vascular Surgery, Beijing, 100050, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Division of Tongzhou Medical Center, Department of Vascular Surgery, Beijing Friendship Hospital, Capital Medical University, No. 101 Lu'yuan East Road, Tongzhou District, Beijing, 101125, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y" EqualContrib="Y"><LastName>Zhang</LastName><ForeName>Li</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Department of Disease Surveillance, Center for Disease Control and Prevention, Central Theater Command, No. 66 Heishitou Road, Beijing, 100042, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y" EqualContrib="Y"><LastName>Li</LastName><ForeName>Wenrui</ForeName><Initials>W</Initials><AffiliationInfo><Affiliation>Division of Xicheng Medical Center, Department of Vascular Surgery, Beijing Friendship Hospital, Capital Medical University, No. 95 Yong'an Road, Xicheng District, Beijing, 100050, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Beijing Center of Vascular Surgery, Beijing, 100050, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Division of Tongzhou Medical Center, Department of Vascular Surgery, Beijing Friendship Hospital, Capital Medical University, No. 101 Lu'yuan East Road, Tongzhou District, Beijing, 101125, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zhang</LastName><ForeName>Yun-Xin</ForeName><Initials>YX</Initials><AffiliationInfo><Affiliation>Department of Vascular Surgery, Beijing Jishuitan Hospital, No. 31 Xinjiekou East Street, Xicheng District, Beijing, 100035, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Yin</LastName><ForeName>Wei</ForeName><Initials>W</Initials><AffiliationInfo><Affiliation>Division of Xicheng Medical Center, Department of Radiology, Beijing Friendship Hospital, Capital Medical University, No. 95 Yong'an Road, Xicheng District, Beijing, 100050, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Guo</LastName><ForeName>Xiaobo</ForeName><Initials>X</Initials><AffiliationInfo><Affiliation>Division of Xicheng Medical Center, Department of Vascular Surgery, Beijing Friendship Hospital, Capital Medical University, No. 95 Yong'an Road, Xicheng District, Beijing, 100050, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Beijing Center of Vascular Surgery, Beijing, 100050, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Division of Tongzhou Medical Center, Department of Vascular Surgery, Beijing Friendship Hospital, Capital Medical University, No. 101 Lu'yuan East Road, Tongzhou District, Beijing, 101125, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zhang</LastName><ForeName>Jie</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Department of Vascular Surgery, Beijing Luhe Hospital, Capital Medical University, Beijing, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wang</LastName><ForeName>Yan</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Department of Vascular Surgery, Beijing Tiantan Hospital, Capital Medical University, Beijing, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Chen</LastName><ForeName>Xueming</ForeName><Initials>X</Initials><AffiliationInfo><Affiliation>Division of Xicheng Medical Center, Department of Vascular Surgery, Beijing Friendship Hospital, Capital Medical University, No. 95 Yong'an Road, Xicheng District, Beijing, 100050, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Beijing Center of Vascular Surgery, Beijing, 100050, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Division of Tongzhou Medical Center, Department of Vascular Surgery, Beijing Friendship Hospital, Capital Medical University, No. 101 Lu'yuan East Road, Tongzhou District, Beijing, 101125, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Feng</LastName><ForeName>Hai</ForeName><Initials>H</Initials><Identifier Source="ORCID">0000-0001-9508-0696</Identifier><AffiliationInfo><Affiliation>Division of Xicheng Medical Center, Department of Vascular Surgery, Beijing Friendship Hospital, Capital Medical University, No. 95 Yong'an Road, Xicheng District, Beijing, 100050, China. vascusugfh@ccmu.edu.cn.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Beijing Center of Vascular Surgery, Beijing, 100050, China. vascusugfh@ccmu.edu.cn.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Division of Tongzhou Medical Center, Department of Vascular Surgery, Beijing Friendship Hospital, Capital Medical University, No. 101 Lu'yuan East Road, Tongzhou District, Beijing, 101125, China. vascusugfh@ccmu.edu.cn.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Liu</LastName><ForeName>Ming-Yuan</ForeName><Initials>MY</Initials><Identifier Source="ORCID">0000-0002-6449-4885</Identifier><AffiliationInfo><Affiliation>Division of Xicheng Medical Center, Department of Vascular Surgery, Beijing Friendship Hospital, Capital Medical University, No. 95 Yong'an Road, Xicheng District, Beijing, 100050, China. dr.mingyuanliu@pku.edu.cn.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Beijing Center of Vascular Surgery, Beijing, 100050, China. dr.mingyuanliu@pku.edu.cn.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Division of Tongzhou Medical Center, Department of Vascular Surgery, Beijing Friendship Hospital, Capital Medical University, No. 101 Lu'yuan East Road, Tongzhou District, Beijing, 101125, China. dr.mingyuanliu@pku.edu.cn.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>CFH2020-2-1102</GrantID><Agency>Capital's Funds for Health Improvement and Research</Agency><Country /></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016448">Multicenter Study</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2024</Year><Month>10</Month><Day>01</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Sci Rep</MedlineTA><NlmUniqueID>101563288</NlmUniqueID><ISSNLinking>2045-2322</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086382" MajorTopicYN="Y">COVID-19</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName><QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D058729" MajorTopicYN="Y">Peripheral Arterial Disease</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D003430" MajorTopicYN="N">Cross-Sectional Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D002681" MajorTopicYN="N" Type="Geographic">China</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086402" MajorTopicYN="N">SARS-CoV-2</DescriptorName><QualifierName UI="Q000302" MajorTopicYN="N">isolation &amp; purification</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D017719" MajorTopicYN="N">Diabetic Foot</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006760" MajorTopicYN="N">Hospitalization</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D058873" MajorTopicYN="N">Pandemics</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012307" MajorTopicYN="N">Risk Factors</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000369" MajorTopicYN="N">Aged, 80 and over</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Amputation</Keyword><Keyword MajorTopicYN="N">COVID-19</Keyword><Keyword MajorTopicYN="N">Critical limb threatening ischemia</Keyword><Keyword MajorTopicYN="N">Diabetic foot infection</Keyword><Keyword MajorTopicYN="N">Peripheral arterial disease</Keyword></KeywordList><CoiStatement>The authors declare no competing interests.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2024</Year><Month>3</Month><Day>24</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2024</Year><Month>8</Month><Day>26</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>10</Month><Day>2</Day><Hour>7</Hour><Minute>21</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>10</Month><Day>2</Day><Hour>7</Hour><Minute>20</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>10</Month><Day>1</Day><Hour>23</Hour><Minute>19</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2024</Year><Month>10</Month><Day>1</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">39353960</ArticleId><ArticleId IdType="pmc">PMC11445429</ArticleId><ArticleId IdType="doi">10.1038/s41598-024-71247-z</ArticleId><ArticleId IdType="pii">10.1038/s41598-024-71247-z</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Canale, M. P., Menghini, R., Martelli, E. &amp; Federici, M. COVID-19-associated endothelial dysfunction and microvascular injury: From pathophysiology to clinical manifestations. Card. Electrophysiol. Clin.14, 21–28. 10.1016/j.ccep.2021.10.003 (2022).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8556628</ArticleId><ArticleId IdType="pubmed">35221082</ArticleId></ArticleIdList></Reference><Reference><Citation>Kwenandar, F. et al. Coronavirus disease 2019 and cardiovascular system: A narrative review. Int. J. Cardiol. Heart Vasc.29, 100557. 10.1016/j.ijcha.2020.100557 (2020).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7266760</ArticleId><ArticleId IdType="pubmed">32550259</ArticleId></ArticleIdList></Reference><Reference><Citation>Fernandez-Nieto, D. et al. Characterization of acute acral skin lesions in nonhospitalized patients: A case series of 132 patients during the COVID-19 outbreak. J. Am. Acad. Dermatol.83, e61–e63. 10.1016/j.jaad.2020.04.093 (2020).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7195051</ArticleId><ArticleId IdType="pubmed">32339703</ArticleId></ArticleIdList></Reference><Reference><Citation>Piazza, G. &amp; Morrow, D. A. Diagnosis, management, and pathophysiology of arterial and venous thrombosis in COVID-19. JAMA324, 2548–2549. 10.1001/jama.2020.23422 (2020).</Citation><ArticleIdList><ArticleId IdType="pubmed">33226423</ArticleId></ArticleIdList></Reference><Reference><Citation>Martelli, E. et al. How the first year of the COVID-19 pandemic impacted patients' hospital admission and care in the vascular surgery divisions of the southern regions of the Italian Peninsula. J. Pers. Med. 12. 10.3390/jpm12071170 (2022).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9316551</ArticleId><ArticleId IdType="pubmed">35887667</ArticleId></ArticleIdList></Reference><Reference><Citation>de Athayde Soares, R., de Arruda Caceres, N., Barbosa, A. G., Matielo, M. F. &amp; Sacilotto, R. The catastrophic impact of COVID-19 infection in patients with chronic limb-threatening ischemia. Surgery171, 1422–1426. 10.1016/j.surg.2021.10.016 (2022).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8529269</ArticleId><ArticleId IdType="pubmed">34742566</ArticleId></ArticleIdList></Reference><Reference><Citation>Piazza, M. et al. The challenge of maintaining necessary vascular and endovascular services at a referral center in Northern Italy during the COVID-19 outbreak. Vascular29, 477–485. 10.1177/1708538120962964 (2021).</Citation><ArticleIdList><ArticleId IdType="pubmed">33054679</ArticleId></ArticleIdList></Reference><Reference><Citation>Miranda, J. A., Chung, J. &amp; Mills, J. L. Influence of the COVID-19 pandemic on the management of chronic limb-threatening ischemia. Semin. Vasc. Surg.34, 89–95. 10.1053/j.semvascsurg.2021.05.006 (2021).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9761861</ArticleId><ArticleId IdType="pubmed">34642041</ArticleId></ArticleIdList></Reference><Reference><Citation>Lou, J. Y. et al. North American lower-extremity revascularization and amputation during COVID-19: Observations from the vascular quality initiative. Vasc. Med.26, 613–623. 10.1177/1358863X211021918 (2021).</Citation><ArticleIdList><ArticleId IdType="pubmed">34169796</ArticleId></ArticleIdList></Reference><Reference><Citation>Stabile, E. et al. A cross-sectional study evaluating hospitalization rates for chronic limb-threatening ischemia during the COVID-19 outbreak in Campania Italy. Vasc. Med.26, 174–179. 10.1177/1358863X20977678 (2021).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8033437</ArticleId><ArticleId IdType="pubmed">33332228</ArticleId></ArticleIdList></Reference><Reference><Citation>Data, W. C. https://www.worldometers.info/coronavirus/country/china/. Worldometer manually analyzes, validates, and aggregates data from thousands of sources in real time and provides global COVID-19 live statistics for a wide audience of caring people around the world. (Accessed on July 7, 2023).</Citation></Reference><Reference><Citation>Jin, H., Lu, L., Liu, J. &amp; Cui, M. COVID-19 emergencies around the globe: China's experience in controlling COVID-19 and lessons learned. Int. J. Qual. Health Care33, 1. 10.1093/intqhc/mzaa143 (2021).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7799047</ArticleId><ArticleId IdType="pubmed">33320189</ArticleId></ArticleIdList></Reference><Reference><Citation>Rooke, T. W. et al. Management of patients with peripheral artery disease (compilation of 2005 and 2011 ACCF/AHA Guideline Recommendations): A report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. J. Am. Coll. Cardiol.61, 1555–1570. 10.1016/j.jacc.2013.01.004 (2013).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4492473</ArticleId><ArticleId IdType="pubmed">23473760</ArticleId></ArticleIdList></Reference><Reference><Citation>Norgren, L. et al. Inter-society consensus for the management of peripheral arterial disease (TASC II). J. Vasc. Surg.45(Suppl S), S5-67. 10.1016/j.jvs.2006.12.037 (2007).</Citation><ArticleIdList><ArticleId IdType="pubmed">17223489</ArticleId></ArticleIdList></Reference><Reference><Citation>Conte, M. S. et al. Global vascular guidelines on the management of chronic limb-threatening ischemia. Eur. J. Vasc. Endovasc. Surg.58, S1-S109 e133. 10.1016/j.ejvs.2019.05.006 (2019).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8369495</ArticleId><ArticleId IdType="pubmed">31182334</ArticleId></ArticleIdList></Reference><Reference><Citation>Obara, H., Matsubara, K. &amp; Kitagawa, Y. Acute Limb Ischemia. Ann. Vasc. Dis.11, 443–448. 10.3400/avd.ra.18-00074 (2018).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6326052</ArticleId><ArticleId IdType="pubmed">30636997</ArticleId></ArticleIdList></Reference><Reference><Citation>Zeller, T. et al. Directional atherectomy followed by a paclitaxel-coated balloon to inhibit restenosis and maintain vessel patency: Twelve-month results of the DEFINITIVE AR study. Circ. Cardiovasc. Interv.10, 1. 10.1161/CIRCINTERVENTIONS.116.004848 (2017).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5610565</ArticleId><ArticleId IdType="pubmed">28916599</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhan, L. X., Branco, B. C., Armstrong, D. G. &amp; Mills, J. L. Sr. The Society for Vascular Surgery lower extremity threatened limb classification system based on Wound, Ischemia, and foot Infection (WIfI) correlates with risk of major amputation and time to wound healing. J. Vasc. Surg.61, 939–944. 10.1016/j.jvs.2014.11.045 (2015).</Citation><ArticleIdList><ArticleId IdType="pubmed">25656592</ArticleId></ArticleIdList></Reference><Reference><Citation>Darling, J. D. et al. Predictive ability of the Society for Vascular Surgery Wound, Ischemia, and foot Infection (WIfI) classification system after first-time lower extremity revascularizations. J. Vasc. Surg.65, 695–704. 10.1016/j.jvs.2016.09.055 (2017).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5328924</ArticleId><ArticleId IdType="pubmed">28073665</ArticleId></ArticleIdList></Reference><Reference><Citation>Mills, J. L. Sr. et al. The Society for Vascular Surgery Lower Extremity Threatened Limb Classification System: Risk stratification based on wound, ischemia, and foot infection (WIfI). J. Vasc. Surg.59(220–234), e221-222. 10.1016/j.jvs.2013.08.003 (2014).</Citation><ArticleIdList><ArticleId IdType="pubmed">24126108</ArticleId></ArticleIdList></Reference><Reference><Citation>Stoner, M. C. et al. Reporting standards of the Society for Vascular Surgery for endovascular treatment of chronic lower extremity peripheral artery disease. J. Vasc. Surg.64, e1–e21. 10.1016/j.jvs.2016.03.420 (2016).</Citation><ArticleIdList><ArticleId IdType="pubmed">27345516</ArticleId></ArticleIdList></Reference><Reference><Citation>Sharma, S., Kerry, C., Atway, S., &amp; Ramanujam, C. Diabetic Foot Infections. In StatPearls. Treasure Island (FL): StatPearls Publishing. Retrieved from https://www.ncbi.nlm.nih.gov/books/NBK441914/ (2023).</Citation></Reference><Reference><Citation>Li, W., Chen, X. &amp; Feng, H. Strategies and recommendations for the safe implementation of vascular surgery during the pandemic period of novel coronavirus pneumonia. J. Vasc. Surg.72, 377–378. 10.1016/j.jvs.2020.04.466 (2020).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7175885</ArticleId><ArticleId IdType="pubmed">32334048</ArticleId></ArticleIdList></Reference><Reference><Citation>Sena, G. &amp; Gallelli, G. An increased severity of peripheral arterial disease in the COVID-19 era. J. Vasc. Surg.72, 758. 10.1016/j.jvs.2020.04.489 (2020).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7192106</ArticleId><ArticleId IdType="pubmed">32360372</ArticleId></ArticleIdList></Reference><Reference><Citation>Schuivens, P. M. E. et al. Impact of the COVID-19 lockdown strategy on vascular surgery practice: More major amputations than usual. Ann. Vasc. Surg.69, 74–79. 10.1016/j.avsg.2020.07.025 (2020).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7402273</ArticleId><ArticleId IdType="pubmed">32763458</ArticleId></ArticleIdList></Reference><Reference><Citation>Noory, E. et al. Impact of COVID-19 pandemic on clinical care of peripheral arterial disease patients: A single-center experience. J. Clin. Med.12, 1. 10.3390/jcm12030890 (2023).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9918042</ArticleId><ArticleId IdType="pubmed">36769538</ArticleId></ArticleIdList></Reference><Reference><Citation>Zayed, H. et al. Impact of COVID-19 pandemic on the outcomes in patients with critical limb threatening ischaemia and diabetic foot infection. Ann. Surg.275, 1037–1042. 10.1097/SLA.0000000000004677 (2022).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9132240</ArticleId><ArticleId IdType="pubmed">33630476</ArticleId></ArticleIdList></Reference><Reference><Citation>Smolderen, K. G., Lee, M., Arora, T., Simonov, M. &amp; Mena-Hurtado, C. Peripheral artery disease and COVID-19 outcomes: Insights from the Yale DOM-CovX registry. Curr. Probl. Cardiol.47, 101007. 10.1016/j.cpcardiol.2021.101007 (2022).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8496926</ArticleId><ArticleId IdType="pubmed">34627824</ArticleId></ArticleIdList></Reference><Reference><Citation>Bilaloglu, S. et al. Thrombosis in Hospitalized Patients With COVID-19 in a New York City Health System. JAMA324, 799–801. 10.1001/jama.2020.13372 (2020).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7372509</ArticleId><ArticleId IdType="pubmed">32702090</ArticleId></ArticleIdList></Reference><Reference><Citation>Batatinha, H. A. P., Kruger, K. &amp; Rosa Neto, J. C. Thromboinflammation and COVID-19: The role of exercise in the prevention and treatment. Front. Cardiovasc. Med.7, 582824. 10.3389/fcvm.2020.582824 (2020).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7775570</ArticleId><ArticleId IdType="pubmed">33392268</ArticleId></ArticleIdList></Reference><Reference><Citation>Rodway, A. D. et al. Understanding the impact of COVID-19 on angioplasty service and outcome of patients treated for chronic limb-threatening ischaemia: A single-centre retrospective cohort study. Biomedicines11, 1. 10.3390/biomedicines11072034 (2023).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10377405</ArticleId><ArticleId IdType="pubmed">37509673</ArticleId></ArticleIdList></Reference><Reference><Citation>Ritti-Dias, R. M. et al. Impact of the COVID-19 pandemic on health lifestyle in patients with peripheral artery disease: A cross-sectional study. J. Vasc. Nurs.40, 54–58. 10.1016/j.jvn.2022.01.001 (2022).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8743617</ArticleId><ArticleId IdType="pubmed">35287835</ArticleId></ArticleIdList></Reference><Reference><Citation>Sasko, B. et al. Impact of the COVID-19 pandemic on hospital admission rates for arterial hypertension and coronary heart disease: a German database study. Front. Cardiovasc. Med.11, 1333749. 10.3389/fcvm.2024.1333749 (2024).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC11135167</ArticleId><ArticleId IdType="pubmed">38812747</ArticleId></ArticleIdList></Reference><Reference><Citation>Bhatt, A. S. et al. Fewer hospitalizations for acute cardiovascular conditions during the COVID-19 pandemic. J. Am. Coll. Cardiol.76, 280–288. 10.1016/j.jacc.2020.05.038 (2020).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7250561</ArticleId><ArticleId IdType="pubmed">32470516</ArticleId></ArticleIdList></Reference><Reference><Citation>Smith, A. C. et al. Telehealth for global emergencies: Implications for coronavirus disease 2019 (COVID-19). J. Telemed. Telecare26, 309–313. 10.1177/1357633X20916567 (2020).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7140977</ArticleId><ArticleId IdType="pubmed">32196391</ArticleId></ArticleIdList></Reference><Reference><Citation>Katulanda, P. et al. Prevention and management of COVID-19 among patients with diabetes: An appraisal of the literature. Diabetologia63, 1440–1452. 10.1007/s00125-020-05164-x (2020).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7220850</ArticleId><ArticleId IdType="pubmed">32405783</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle>